You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 58 No. 11, November 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Basic Science Seminars in Neurology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (12)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Neurogenetics
 •Genetic Disorders
 •Genetics, Other
 •Alert me on articles by topic

Sequence Analysis of the Human Genome

Implications for the Understanding of Nervous System Function and Disease

Anibal Cravchik, MD, PhD; G. Subramanian, MD, PhD; Samuel Broder, MD; J. Craig Venter, PhD

Arch Neurol. 2001;58:1772-1778.

The recent publication of the sequence of the human genome will accelerate the discovery of new genetic susceptibility factors for human disease, leading to the development of novel diagnostics and therapeutics. The exhaustive analysis of the human genome sequence will be the focus of the biomedical research community for many years to come. In particular, comparative analysis of the available eukaryotic genome sequences is an important approach to further our understanding of gene structure, function, and evolution. Our initial analysis of the human genome sequence has revealed many interesting features that are relevant to nervous system function, evolution, and disease. We analyzed the prominent features of predicted human proteins involved in neuronal function and prepared a comparative analysis of 146 human genes that have alleles (or mutations) conferring susceptibility for 168 neurologic diseases.


From Celera Genomics, Rockville, Md.

Corresponding author and reprints: Anibal Cravchik, MD, PhD, Celera Genomics, 45 W Gude Dr, Rockville, MD 20850 (e-mail: Anibal.Cravchik{at}celera.com).


RELATED ARTICLES

Genomics and the Transformation of Neurology
Roger N. Rosenberg
JAMA. 2001;286(22):2869-2870.
EXTRACT | FULL TEXT  

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2001;58(11):1942-1944.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Conserved transcription factor binding sites of cancer markers derived from primary lung adenocarcinoma microarrays
Yap et al.
Nucleic Acids Res 2005;33:409-421.
ABSTRACT | FULL TEXT  

Tales From the Neural Genome: The Lessons of Homozygous Porphyria
Wilson
Arch Neurol 2004;61:1650-1651.
FULL TEXT  

Neurology: Then, Now, and in the Future
McKhann
Arch Neurol 2002;59:1369-1373.
FULL TEXT  

Genomics and the Transformation of Neurology
Rosenberg
JAMA 2001;286:2869-2870.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.